🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Cabotegravir Injectable Suspension

Found 21 matching trials

Study to Evaluate the Safety Tolerability and Acceptability of Long Acting Injections of the Human Immunodeficiency Virus (HIV) Integrase Inhibitor, GSK1265744, in HIV Uninfected Men (ECLAIR)

PHASE2

This study is a Phase IIa, randomized, multi-site, two-arm, double-blinded ...

Status

Completed

Location

GSK Investigational Site

Start Date

2014-03-27

Trial ID

NCT02076178

Treatments Being Tested

744 Tablet 744 LA Injection Placebo Tablet Placebo Injection

Impact of Long-acting Injectable Cabotegravir for HIV PrEP in MSM in France.

PHASE3

The purpose of this study is to evaluate if offering long-acting injectable...

Status

Not Yet Recruiting

Location

Hôpital Hôtel Dieu

Start Date

2024-04-01

Trial ID

NCT06273943

Treatments Being Tested

Cabotegravir Tablets, for oral use.Cabotegravir Extended-Release Injectable Suspension, for intramuscular use.Tenofovir disoproxil/Emtricitabine 300mg/200mg fixed-dose combination tablets, for oral use Rectal Biopsies

Efficacy, Safety and Tolerability Study of Long-acting Cabotegravir Plus Long-acting Rilpivirine (CAB LA + RPV LA) in Human-immunodeficiency Virus-1 (HIV-1) Infected Adults

PHASE3

This Antiretroviral Therapy as Long Acting Suppression every 2 Months (ATLA...

Status

Active Not Recruiting

Location

GSK Investigational Site

Start Date

2017-10-27

Trial ID

NCT03299049

Treatments Being Tested

Cabotegravir Tablets Rilpivirine Tablets Cabotegravir Injectable Suspension Rilpivirine Injectable Suspension

Oregon PrEP at Home Study

N/A

This demonstration study will evaluate the real-world implementation of lon...

Status

Unknown

Location

Oregon Health & Science University

Start Date

2023-12-01

Trial ID

NCT05949203

Treatments Being Tested

Cabotegravir Injection

Long-Acting Treatment in Adolescents (LATA)

PHASE3

The LATA trial will find out if taking a long-acting injectable form of HIV...

Status

Unknown

Location

Moi University

Start Date

2023-06-22

Trial ID

NCT05154747

Treatments Being Tested

Cabotegravir, Rilpivirine Drug Combination TLD

A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult Subjects

PHASE2

This study is a Phase IIb, randomized, multicentre, parallel group, open-la...

Status

Completed

Location

GSK Investigational Site

Start Date

2014-04-28

Trial ID

NCT02120352

Treatments Being Tested

CAB Oral Tablets CAB LA ABC/3TC Oral tablets RPV Oral Tablets HAART RPV

A Randomized Study to Assess the Relative Bioavailability of New Formulations of GSK1265744 Long Acting Parental (LAP) in Healthy Adult Subjects

PHASE1

This is a single-center, randomized, open-label, 3 parallel treatment study...

Status

Completed

Location

GSK Investigational Site

Start Date

2013-01

Trial ID

NCT01754116

Treatments Being Tested

GSK1265744 30 mg oral Midazolam 3 mg oral + GSK1265744 30mg oral GSK1265744 400 mg (200 nm)GSK1265744 400 mg (1 micro m)GSK1265744 400 mg (5 micro m)

Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults

PHASE3

The Antiretroviral Therapy as Long Acting Suppression (ATLAS) study is bein...

Status

Active Not Recruiting

Location

GSK Investigational Site

Start Date

2016-10-28

Trial ID

NCT02951052

Treatments Being Tested

Cabotegravir (CAB) tablet Rilpivirine (RPV) tablet Cabotegravir - Injectable Suspension (CAB LA)Rilpivirine - Injectable Suspension (RPV LA)2 NRTIs plus an INI, NNRTI, or PI

Study to Assess the Effects of Cabotegravir (CAB) and Rilpivirine (RPV) Long-Acting (LA) Injections Following Sub-cutaneous (SC) Administration Compared With Intramuscular (IM) Administration in Adult Participants Living With Human Immunodeficiency Virus (HIV-1) Infection in the FLAIR Study

PHASE3

This study will assess the pharmacokinetics, safety, tolerability, maintena...

Status

Completed

Location

GSK Investigational Site

Start Date

2022-11-08

Trial ID

NCT05896748

Treatments Being Tested

Cabotegravir - Injectable Suspension (CAB LA)Rilpivirine - Injectable Suspension (RPV LA)

Safety and Acceptability of Cabotegravir in HIV Uninfected Women in KwaZulu-Natal, South Africa

PHASE2

The CAPRISA 014 trial aims to assess the safety and acceptability of the lo...

Status

Withdrawn

Location

CAPRISA eThekwini Research Clinic

Start Date

2015-10

Trial ID

NCT02462772

Treatments Being Tested

cabotegravir Placebo

Previous Next